Plainsboro, NJ, United States of America

Zhaoning Zhu

USPTO Granted Patents = 71 (Patent Applications = 12)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 22 (Patent Applications = 23)

Average Co-Inventor Count = 7.4

ph-index = 9

Forward Citations = 464(Granted Patents)

Forward Citations (Not Self Cited) = 398(Oct 12, 2025)

Inventors with similar research interests:

Location History:

East Windsor, NJ (US) (2002 - 2012)
Warfield, GB (2015)
Plainsboro, NJ (US) (2005 - 2016)
Warfield Berkshire, GB (2017)
Slough, GB (2016 - 2022)

Company Filing History:

Merck Sharp + Dohme Corp.

Pharmacopeia Drug Discovery, Inc.

9. 3 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2022

Loading Chart...

71 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11479546 - Antimalarial hexahydropyrimidine analogues (2022-10-25),

2. 11472794 - Fused imidazole derivatives as IL-17 modulators (2022-10-18),

3. 11136310 - Iminotetrahydropyrimidinone derivatives as plasmepsin V inhibitors (2021-10-05),

4. 11052076 - Spirocyclic indolines as IL-17 modulators (2021-07-06),

5. 10980814 - Fused pentacyclic imidazole derivatives as modulators of TNF activity (2021-04-20),

6. 10953019 - Fused pentacyclic imidazole derivatives as modulators of TNF activity (2021-03-23),

7. 10906919 - Fused pentacyclic imidazole derivatives (2021-02-02),

8. 10464932 - Iminothiadiazinane dioxide derivatives as plasmepsin V inhibitors (2019-11-05),

9. 10287299 - Substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines as modulators of tumor necrosis factor activity (2019-05-14),

10. 10202405 - Fused pentacyclic imidazole derivatives (2019-02-12),

11. 10087179 - Fused tricyclic imidazole derivatives as modulators of TNF activity (2018-10-02),

12. 10004737 - Fused imidazole and pyrazole derivatives as modulators of TNF activity (2018-06-26),

13. 9932343 - Fused tricyclic benzimidazoles derivatives as modulators of TNF activity (2018-04-03),

14. 9890174 - Fused Tricyclic imidazole derivatives as modulators of TNF activity (2018-02-13),

15. 9815797 - Fused bicyclic heteroaromatic derivatives as modulators of TNF activity (2017-11-14),

Title: The Innovative Journey of Zhaoning Zhu

Introduction: Zhaoning Zhu, a talented inventor based in Plainsboro, NJ (US), has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Zhaoning Zhu holds several patents in various technological domains, showcasing his versatility and creativity in innovation.

Career Highlights: Throughout his illustrious career, Zhaoning Zhu has demonstrated a keen ability to identify gaps in the market and develop innovative solutions to address them. His passion for technology and commitment to excellence have led to the successful commercialization of several of his inventions.

Collaborations: Zhaoning Zhu has collaborated with leading research institutions, universities, and companies to further his research and bring his inventions to life. His collaborative spirit and dedication to teamwork have been instrumental in the success of his projects.

Conclusion: Zhaoning Zhu's innovative spirit, coupled with his dedication to pushing the boundaries of technology, has established him as a prominent figure in the world of inventions. His contributions continue to inspire future generations of inventors to think outside the box and pursue their creative ideas relentlessly.

This text is generated by artificial intelligence and may not be accurate.